Weekly news of Life Science Área! 22/09/2020
The German BioNTech,which produces a potential vaccine against Covid-19 with the American Pfizer,said in a statement on Thursday (17) that signed the purchase of a laboratoryof Novartis, pharmaceutical company. The acquisition, according to BioNTech,will serve for the biotechnology company to expand vaccine production to atotal of 750 million doses per year.
Farmaceutical, sanitizers and cosmetic sanitizers companies may manufacture antiseptic preparations or disinfectants without registration or notification with Anvisa provided that the criteria set out in the new resolution are met.
The resolution has the objective of defining the requirements of the notification regime for the sanitary control of medical products of risk classes I and II, exempted from registration in the form of §1 of Article 25 of Law No. 6,360 of 1976."(NR)
Sign Up now in our newsletter to have all of it in you e-mail by morning!